GLENMEDE TRUST CO NA
BankPosition in CPRX — Catalyst Pharmaceuticals, Inc.
CIK 314949
PHILADELPHIA, PA
Position in CPRX
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$13,999,896
-$429,311 QoQ
Shares Held
565,424
-8.5% QoQ
Ownership
0.462%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in CPRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $121,496,870 across 47 Biotechnology names. CPRX ranks #2 (11.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
523,291 | $49,252,148 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
This page
|
565,424 | $13,999,896 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,059 | $13,953,104 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
146,717 | $9,482,319 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
|
405,892 | $9,035,155 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,608 | $2,504,195 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,819 | $1,478,181 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
6,716 | $1,135,138 |
All Filings in CPRX
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $13,999,896 | 565,424 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $14,429,207 | 618,218 | Shares | Sole | 2026-02-17 | |
| 2025-03-31 | $2,084,941 | 85,977 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,976,096 | 94,686 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,028,395 | 102,032 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,573,768 | 101,599 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,599,578 | 100,350 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,692,397 | 100,678 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $565,538 | 48,378 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $380,324 | 28,298 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $469,180 | 28,298 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $219,405 | 17,101 | Shares | Sole | 2022-11-16 | |
| 2022-06-30 | $122,667 | 17,499 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $184,875 | 22,301 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $150,977 | 22,301 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $118,195 | 22,301 | Shares | Sole | 2021-11-15 | |
| 2020-09-30 | $7,169 | 2,414 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,857 | 835 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||